Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Organisation › Details

Alder Biopharmaceuticals Inc.

https://www.alderbio.com

	Start	2004-01-01 established
	Group	Lundbeck (Group)
	Industry	therapeutic antibody
	Industry 2	eptinezumab (anti-CGRP mAb)

	Region	Bothell, WA
	Country	United States (USA)
	Street	11804 North Creek Parkway South
	City	98011 Bothell, WA
	Tel	+1-425-205-2900
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2023-07-10

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Lundbeck (Group)

[1] IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY....
[2] H. Lundbeck A/S. (4/8/22). "Press Release: Joerg Hornstein to Join Lundbeck as Chief Financial Officer and Head of Corporate Functions". Valby....
[3] Lundbeckfonden. (4/4/22). "Press Release: Lundbeck Foundation Shifts into New Biotech Gear. New unit Raises Ambitions in Denmark – Lundbeckfonden BioCapital"....
[4] Capsida Biotherapeutics Inc.. (12/7/21). "Press Release: Capsida Biotherapeutics Poised to Capitalize on Industry-leading Gene Therapy Technology With New CEO, CSO, and CTO". Thousand Oaks, CA....
[5] H. Lundbeck A/S. (11/29/21). "Press Release: Lundbeck Announces Changes to Executive Management". Valby....
[6] H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Announces Phase IIa Study Results of Lu AG06466 in Adults with Tourette Syndrome". Valby....
[7] CytomX Therapeutics, Inc.. (3/23/20). "Press Release: CytomX Therapeutics Announces Appointment of Carlos Campoy as Chief Financial Officer". South San Francisco, CA....
[8] H. Lundbeck A/S. (10/22/19). "Press Release: Lundbeck Completes the Acquisition of Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention". Valby....
[9] H. Lundbeck A/S. (9/16/19). "Press Release: Lundbeck to Acquire Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention – in a Transaction Valued at up to USD 1.95 Billion Net of Cash". Valby & Bothell, WA....
[10] Athira Pharma, Inc.. (7/11/19). "Press Release: Athira Pharma Announces Appointment of Mark Litton as Chief Operating Officer"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]